AI Article Synopsis
- * Participants aged 12-19 took the IgY tablets for 15 days, and saliva samples were collected at various intervals to measure bacterial levels.
- * Results showed that the IgY tablets significantly decreased bacterial counts, suggesting they can be a helpful addition to oral hygiene practices during orthodontic treatment.
Article Abstract
Aim: The aim of the study was to determine the efficacy of commercially available immunoglobulin Y (IgY) chewable tablets on () count in patients undergoing orthodontic treatment.
Materials And Methods: Participants aged between 12 and 19 years who had fixed, nonextraction orthodontic treatment with no carious lesion were included in the study and advised to take IgY chewable tablet for 15 days (one course) and saliva samples were collected from the patients on day 61, 91, and 121 days from the placement of fixed appliance, to assess its ability in reduction of count The collected samples were processed, and levels were estimated. The results were tabulated and subjected to statistical analysis using Statistical Package for the Social Sciences (SPSS) version 20, and the repeated measures test was used to compare different groups.
Results: Immunoglobulin Y (IgY) chewable tablet was found to be significantly effective in decreasing counts in patients undergoing orthodontic treatment during the study period.
Conclusion: Oral passive immunotherapy egg yolk antibody IgY effectively decreased the level, which was found to increase during orthodontic fixed appliance treatment.
Clinical Significance: The IgY chewable tablets can be used as an adjuvant to reduce counts and provide basic oral hygiene measures.
How To Cite This Article: Muthukumaran M, Jayaprakash J, Arangannal P, Efficacy of Immunoglobulin Y Chewable Tablets on Count in Patients Undergoing Orthodontic Treatment. Int J Clin Pediatr Dent 2024;17(3):265-269.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320804 | PMC |
| http://dx.doi.org/10.5005/jp-journals-10005-2774 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy of Natural β-Carotene Chewable Tablets Derived from Banana ( AA) Pulp in Reducing UV-Induced Skin Erythema.
Nutrients
December 2024
Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences and Center of Excellence for Innovation in Chemistry, Naresuan University, Phitsanulok 65000, Thailand.
Background/objectives: UV radiation is a primary cause of skin damage and photoaging. β-carotene, a potent antioxidant, aids in mitigating UV-induced oxidative stress and enhancing skin photoprotection. This research aimed to evaluate the efficacy of a nutraceutical product designed to prevent photoaging.
View Article and Find Full Text PDFRole as a Probiotic in Children's Health and Disease Prophylaxis-A Systematic Review.
Life (Basel)
December 2024
Physiopathology Department, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania.
Background: This systematic review aimed to synthesize the existing evidence on the use of () probiotics as prophylactic or therapeutic tools for pediatric oral, dental, and respiratory diseases.
Methods: A comprehensive search was carried out across multiple databases using the following terms: , probiotic, children, pediatric.
Results: The systematic literature search identified 613 publications, which were meticulously screened, and, ultimately, 15 suitable citations were included in this systematic review.
Two-Way Randomized Crossover Study to Establish Pharmacodynamic Bioequivalence Between Oxylanthanum Carbonate and Lanthanum Carbonate.
Clin Ther
January 2025
Unicycive Therapeutics, Inc., Los Altos, CA.
Purpose: Phosphate binders (PB) are integral to hyperphosphatemia management in patients with end-stage kidney disease. PB efficacy is adversely affected by nonadherence and limited phosphate-binding capacity relative to dietary intake. Oxylanthanum carbonate is an investigational novel nanotechnology product that combines lanthanum, which has the highest binding capacity of available PBs, with a smaller pill size that is swallowed with water rather than chewed.
View Article and Find Full Text PDFPharmaceutical Equivalence of Film-Coated and Chewable Tablets: A Comparative Dissolution Study Using Pulverized Chewable Tablets.
Pharmaceuticals (Basel)
November 2024
Department of Pharmaceutical Engineering, Cheongju University, Cheongju 28503, Republic of Korea.
Famotidine is a histamine H2 receptor antagonist used in the treatment of gastrointestinal disorders. It is available in multiple formulations, including film-coated tablets, chewable tablets, oral suspension, and injections. The purpose of this study was to develop and evaluate the film-coated tablet (FT) containing famotidine, magnesium hydroxide, and precipitated calcium carbonate, designed to be pharmaceutically equivalent to the marketed chewable tablet (CT).
View Article and Find Full Text PDFPerceived Changes in Anxiety Symptom Burden During Treatment with : A Prospective, Single-Arm Study.
Pharmaceuticals (Basel)
October 2024
Clinical Research Department, Klinik Arlesheim, 4144 Arlesheim, Switzerland.
Background/objectives: spp. preparations are widely used in Anthroposophic Medicine, most often for mental and behavioral disorders, including anxiety. Studies in animals revealed various anxiolytic and neurosedative effects for .
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!